Combined effects of trihexyphenidyl (benzhexol) toxicity, amphetamine-type stimulants and dehydration with renal impairment in a man with cardiomyopathy and morbid obesity
AI-generated summary
A 36-year-old man with schizoaffective disorder, substance abuse issues, and undiagnosed cardiomyopathy died from combined toxicity of benzhexol (prescribed by his GP for tardive dyskinesia), amphetamine-type stimulants, and dehydration with renal impairment. He was on a community treatment order for psychiatric care. Key failures: the deceased's GP did not adequately engage with the community mental health team despite warnings about medication abuse and potential drug interactions; the discharge plan to cease benzhexol was not effectively communicated; high-dose benzhexol (20mg/day) was re-prescribed shortly after discharge when the plan was to cease it; and coordination between primary care and specialist mental health services was inadequate. Better communication, coordinated medication reviews, and early engagement between GP and psychiatrist following discharge could have prevented this.
AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes. Report an inaccuracy.
Specialties
psychiatrygeneral practicecardiologytoxicologyforensic medicine
schizoaffective disorderamphetamine-induced psychosispolysubstance abusecardiomyopathymorbid obesitytardive dyskinesiahypertensionhepatitis Crenal impairmentdehydrationmalignant neuroleptic syndrome (considered but not confirmed)
Contributing factors
High-dose benzhexol prescription (20mg/day) re-prescribed by GP shortly after hospital discharge despite plan to cease
Inadequate communication between GP and community mental health team
Failure of GP to respond to psychiatrist's letter about medication abuse concerns
Discharge summary possibly not received by GP or not acted upon
Patient abuse of prescription medications despite restricted dispensing regime
Undiagnosed cardiomyopathy increasing susceptibility to drug toxicity
Concurrent use of amphetamine-type stimulants with benzhexol and antipsychotics
Morbid obesity and related medical complications
Patient's lack of insight into mental illness and ongoing substance abuse
Absence of real-time prescribing data system preventing awareness of overlapping medications from multiple providers
Coroner's recommendations
Improve coordination and communication between general practitioners and community mental health services, particularly regarding patients with complex medication regimens and substance abuse histories
Implement systematic mechanisms for GPs to engage with specialist mental health teams when discharge plans involve medication changes or cessation
Develop and implement real-time prescribing electronic data systems to provide awareness of all medications prescribed by multiple healthcare providers
Establish protocols for GPs to contact supervising psychiatrists before re-prescribing medications recently ceased or reduced by hospital teams
Include guardianship orders and their outcomes in discharge communications to primary care providers
Ensure discharge summaries explicitly document medication management plans and intended cessation of medications
This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.
Content may be incomplete, reformatted, or summarised. Some material may have been redacted or restricted by court order or privacy requirements. Always refer to the original court publication for the authoritative record.
Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction — report an inaccuracy here.